Financials
Financial year 2025
Dr.T.Braeckevelt – klinische biologie from Ronse, company number BE0884531419, closed financial year 2025 with a result of € 174,881 after tax. For that financial year Dr.T.Braeckevelt – klinische biologie recorded a gross margin of € 305,227 and equity of € 1.8 million. Compared with financial year 2024, the result moved from € 136,112 to € 174,881. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on February 2, 2026.
€ 1.8 million
▲ 7% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 174,881
▲ 28% vs 2024
Profit after tax over the fiscal year.
€ 191,045
▼ 74% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 50,000 paid out
29 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
0
Average over the fiscal year, from the social balance sheet.
€ 7,550
▼ 59% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 12,229
▲ 5% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 21,714
▲ 15% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 634,863 | € 314,635 | € 244,387 | € 305,227 | ▲ 25% |
| Profit after taxes | € 404,242 | € 181,482 | € 136,112 | € 174,881 | ▲ 28% |
| Equity | € 1,493,517 | € 1,674,999 | € 1,712,152 | € 1,837,033 | ▲ 7% |
| Total debts | € 270,022 | € 89,079 | € 64,442 | € 58,004 | ▼ 10% |
| Cash | € 956,084 | € 1,111,245 | € 738,383 | € 191,045 | ▼ 74% |
| Land & buildings | € 445,073 | € 406,731 | € 368,390 | € 330,066 | ▼ 10% |
| Retained profit | € 1,336,857 | € 1,518,339 | € 1,555,492 | € 1,680,373 | ▲ 8% |
| Dividend | € 0 | € 0 | € 98,959 | € 50,000 | ▼ 49% |
| Bank debt | € 89,613 | € 59,742 | € 29,871 | € 0 | ▼ 100% |
| Balance sheet total | € 1,821,968 | € 1,822,507 | € 1,835,022 | € 1,953,466 | ▲ 6% |
By gross margin, Dr.T.Braeckevelt – klinische biologie ranks 37th of 87 companies with main activity “Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied” in East Flanders that publish figures (fiscal year 2025).
Key figures of Dr.T.Braeckevelt – klinische biologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
Ask about Dr.T.Braeckevelt – klinische biologie the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to Dr.T.Braeckevelt – klinische biologie?
What happened at Dr.T.Braeckevelt – klinische biologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 174,881 (▲ 28% vs 2024). filed late Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Ronse. KBO
In short
From € 404,242 profit in 2022 to € 174,881 profit in 2025.
Paid € 411,141 in corporate taxes since 2022.
Best year ever: 2022, with € 404,242 profit.
Paid out € 148,959 in dividends to the owners in total.
Management
Behind Dr.T.Braeckevelt – klinische biologie is Thierry Braeckevelt.
Directors
According to the 2025 annual accounts
Thierry Braeckevelt
Director
Establishments
Establishment units
Physical locations of this company
Maquisstraat 231
9600 Ronse
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in East Flanders
Same main activity (Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied), 132 active companies in East Flanders, largest first.
€ 285.9 million revenue · 2025 · Gent
€ 147.9 million revenue · 2025 · Gent
€ 39.8 million revenue · 2025 · Merelbeke-Melle
€ 38 million revenue · 2025 · Gent
€ 17.5 million revenue · 2025 · Gent
OMEGA PHARMA INNOVATION & DEVELOPMENT
€ 16.3 million revenue · 2025 · Gent
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- BRAECKEVELT Thierry Luc Robert(oprichter) 100%
Details
- Company number
- 0884.531.419
- VAT number
- BE 0884.531.419
- Registered office
- Maquisstraat 231, 9600 Ronse
- Names & denominations
- Dr.T.Braeckevelt – klinische biologie
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 25 October 2006
- Peppol
- Active · Active since 5 Oct 2025
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Verhuur en exploitatie van eigen of geleased niet-residentieel onroerend goed, exclusief terreinen
Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen